Association between hypertension and variation in the α3- and β-adducin genes in a white population

Kidney International

Volumn 62, Issue 6, 2002, Pages 2152-2159

  Wang, Ji Guang ^a,b,c,d   Staessen, Jan A ^a,b,c,d   Barlassina, Cristina ^a,b,c,d   Fagard, Robert ^a,b,c,d   Kuznetsova, Tatiana ^a,b,c,d   Struijker Boudier, Harry A ^a,b,c,d   Zagato, Laura ^a,b,c,d   Citterio, Lorena ^a,b,c,d   Messaggio, Elisabetta ^a,b,c,d   Bianchi, Giuseppe ^a,b,c,d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF MILAN   (Italy)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Adducin; Blood pressure; C1797T polymorphism; Candidate gene; Hypertension; Point mutation; Renin

Indexed keywords

ADDUCIN; CALMODULIN BINDING PROTEIN; ALDOSTERONE; ALPHA ADDUCIN; BETA ADDUCIN; ISOPROTEIN; ORAL CONTRACEPTIVE AGENT; RENIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; RENOVASCULAR HYPERTENSION; SEX RATIO; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENETIC VARIABILITY; HYPERTENSION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALMODULIN-BINDING PROTEINS; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION, RENAL; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX DISTRIBUTION;

EID: 18744395467     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00691.x     Document Type: Article

References (43)

1. Matsuoka Y, Li X, Bennett V: Adducin: Structure, function and regulation. Cell Mol Life Sci 57:884-895, 2000
2. Tripodi G, Valtorta F, Torielli L, et al: Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 97:2815-2822, 1996
3. +-ATPase: Relation to genetic hypertension. Am J Physiol 277:H1338-H1349, 1999
4. Bianchi G, Tripodi G, Casari G, et al: Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci USA 91:3999-4003, 1994
5. Cusi D, Barlassina C, Azzani T, et al: Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 349:1353-1357, 1997
6. Manunta P, Burnier M, D'Amico M, et al: Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension 33:694-697, 1999
7. Manunta P, Cusi D, Barlassina C, et al: α-Adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int 53:1471-1478, 1998
8. Glorioso N, Filligheddu F, Cusi D, et al: α-adducin 460Trp allele is associated with erythrocyte Na transport in North Sardinian primary hypertensives. Hypertension 39 (part 2):357-362, 2002
9. Province MA, Arnett DK, Hunt SC, et al: Association between the α-adducin gene and hypertension in the HyperGEN Study. Am J Hypertens 13:710-718, 2000
10. Barlassina C, Norton GR, Samani NJ, et al: α-Adducin polymorphism in hypertensives of South African ancestry. Am J Hypertens 13:719-723, 2000
11. Ishikawa K, Katsuya T, Sato N, et al: No association between α-adducin 460 polymorphism and essential hypertension in a Japanese population. Am J Hypertens 11:502-506, 1998
12. Kamitani A, Wong ZYH, Fraser H, et al: Human α-adducin gene, blood pressure, and sodium metabolism. Hypertension 32: 138-143, 1998
13. Bianchi G, Cusi D: Association and linkage analysis of α-adducin polymorphism: Is the glass half full or half empty? Am J Hypertens 13:739-743, 2000
14. Gilligan DM, Lozovatsky L, Gwynn B, et al: Targeted disruption of the β adducin gene (Add2) causes red blood cell spherocytosis in mice. Proc Natl Acad Sci USA 96:10717-10722, 1999
15. Muro AF, Marro ML, Gajovic S, et al: Mild spherocytic hereditary elliptocytosis and altered levels of α- and γ-adducins in β-adducin-deficient mice. Blood 95:3978-3985, 2000
16. Marro ML, Scremin OU, Jordan MC, et al: Hypertension in β-adducin-deficient mice. Hypertension 36:449-453, 2000
17. Lin B, Nasir J, McDonald H, et al: Genomic organization of the human α-adducin gene and its alternately spliced isoforms. Genomics 25:93-99, 1995
18. Gilligan DM, Lieman J, Bennett V: Assignment of the human β-adducin gene (ADD2) to 2p13-p14 by in situ hybridization. Genomics 28:610-612, 1995
19. Gilligan DM, Lozovatsky L, Silberfein A: Organization of the human β-adducin gene (ADD2). Genomics 43:141-148, 1997
20. Staessen JA, Roels HA, Emelianov D, et al: Environmental exposure to cadmium, forearm bone-density, and risk of fractures: Prospective population study. Lancet 353:1140-1144, 1999
21. Staessen JA, Fagard R, Amery A: Life style as a determinant of blood pressure in the general population. Am J Hypertens 7:685-694, 1994
22. Livak KJ, Flood SJ, Marmaro J, et al: Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 4:357-362, 1995
23. Staessen JA, Wang JG, Brand E, et al: Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 19:1349-1358, 2001
24. Zeger SL, Liang KY, Albert PS: Models for longitudinal data: A generalized estimating equation approach. Biometrics 44:1049-1060, 1988
25. Holtzman NA, Marteau TM: Will genetics revolutionize medicine? N Engl J Med 343:141-144, 2000
26. Bachman J, Feldmer M, Ganten U, et al: Sexual dimorphism of blood pressure: Possible role of the renin-angiotensin system. J Steroid Biochem Mol Biol 40:511-515, 1991
27. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811, 1999
28. Oparil S: Hormones and vasoprotection. Hypertension 33(part II): 170-176, 1999
29. Oelkers WKH: Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 61:166-171, 1996
30. Hassager C, Riis BJ, Strom V, et al: The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 76:753-758, 1987
31. Gordon DB: The role of renin substrate in hypertension. Hypertension 5:353-362, 1983
32. Staessen JA, Celis H, Fagard R: The epidemiology of the association between hypertension and menopause. J Hum Hypertens 12: 587-592, 1998
33. Kuroski de Bold ML: Estrogen, natriuretic peptides and the renin-angiotensin system. Cardiovasc Res 41:524-531, 1999
34. Staessen JA, Van der Heijden-Spek JJ, Safar ME, et al: Menopause and the characteristics of the large arteries in a population sample. J Hum Hypertens 15:511-518, 2001
35. Waddell TK, Rajkumar C, Cameron JD, et al: Withdrawal of hormonal therapy for 4 weeks decreases arterial compliance in postmenopausal women. J Hypertens 17:413-414, 1999
36. Giacché M, Vuagnat A, Hunt SC, et al: Aldosterone stimulation by angiotensin II. Influence of gender, plasma renin, and familial resemblance. Hypertension 35:710-716, 2000
37. Stachenfeld NS, Dipietro L, Palter SF, et al: Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women. Am J Physiol 274:R187-R195, 1998
38. Boerwinkle E, Family Blood Pressure Program: All for one and one for all: Introduction to a coordinated analysis of the Gly-460-Trp α-adducin polymorphism. Am J Hypertens 13:734-735, 2000
39. Frankel WN, Schork NJ: Who's afraid of epistasis? Nat Genet 14:371-373, 1996
40. Cruickshank JK, Mbanya JC, Wilks R, et al: Sick genes, sick individuals or sick populations with chronic disease? The emergence of diabetes and high blood pressure in African-origin populations. Int J Epidemiol 30:111-117, 2001
41. Grant FD, Romero JR, Jeunemaitre X, et al: Low-renin hypertension, altered sodium homeostasis, and an α-adducin polymorphism. Hypertension 39:191-196, 2002
42. Fisher NDL, Hurwitz S, Jeunemaitre X, et al: Familial aggregation of low-renin hypertension. Hypertension 39:914-918, 2002
43. Tanis BC, Van den Bosch MAAJ, Kemmeren JM, et al: Oral contraceptives and the risk of myocardial infarction. N Engl J Med 345:1787-1793, 2001